StonvexLoading…
StonvexStonvexStonvexCore line items from FNMA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.28B | $28.96B | $21.63B | $14.33B |
Operating Income | $4.66B | $17.98B | $13.57B | $8.74B |
Net Income | $3.72B | $14.36B | $10.84B | $6.98B |
EPS (Diluted) | $0.01 | $0.00 | $0.00 | $0.00 |
Total Assets | $4.31T | $4.32T | $4.34T | $4.34T |
Total Liabilities | $4.20T | $4.21T | $4.23T | $4.24T |
Cash & Equivalents | $45.26B | $42.58B | $39.38B | $38.23B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 1.16B | 1.16B | 1.16B | 1.16B |